The device, still a prototype, can detect diluted samples of COVID-19 and multiple types of early-stage cancer, according to a paper published in Applied Physics Review.
The federal and state government-backed research team said the device’s reliance on silicon chips makes it inexpensive and easily scalable.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
